ChartRow logo
Share this page
ELAN
$22.14+1.70%
as of close, Oct 2, 2026
☾ AH $22.14 +1.70%
Elanco Animal Health IncorporatedStock · Health CareRussell 1000 0.02%US Stock Market 0.02%Russell 3000 0.02%
PeersMRNALLYUNHJNJMRKTMO

ELAN financial statements

The full income statement, balance sheet, and cash-flow statement for Elanco Animal Health Incorporated (ELAN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 494.3M2024-09 494.4M2024-12 494.6M2025-03 496.6M2025-06 496.8M2025-09 496.9M2025-12 497.2M2026-03 499.4M2026-06 499.6M+1.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue4.71B+6.2%4.44B+0.5%4.42B+0.1%4.41B-7.4%4.76B+45.6%
2.59B+6.4%2.44B-2.0%2.49B——
Cost of revenue2.12B+5.9%2.00B+3.7%1.93B+0.9%1.91B-10.3%2.13B+27.9%
Research & development368M+7.0%344M+5.2%327M+1.9%321M-13.0%369M+12.2%
Selling, general & administrative1.43B+8.8%1.31B+2.3%1.28B+1.6%1.26B-9.8%1.40B+40.7%
Restructuring156M+254.5%44.0M0.00+100.0%-7.00M-106.4%110M-29.9%
Amortization of intangibles543M+3.0%527M-3.8%548M+3.8%528M-5.0%556M+54.4%
Interest expense——277M+14.9%241M+2.1%236M+57.3%
Interest & investment income43.0M+38.7%31.0M+675.0%4.00M——
Other non-operating income——-75.0M-134.4%-32.0M-540.0%-5.00M-102.8%
Pre-tax income-224M-145.9%488M+140.8%-1.20B-1559.7%-72.0M+87.4%-571M+15.7%
Income tax8.00M-94.7%150M+316.7%36.0M+500.0%6.00M+106.8%-88.0M+14.6%
Net income-232M-168.6%338M+127.5%-1.23B-1478.2%-78.0M+83.9%-483M+15.9%
-$0.47-169.1%$0.68+127.2%-$2.50-1462.5%-$0.16+83.8%-$0.99+23.8%
EPS (basic)-$0.47-169.1%$0.68+127.2%-$2.50-1462.5%-$0.16+83.8%-$0.99+23.8%
Weighted-avg shares (basic)496M+0.5%494M+0.3%492M+0.8%488M+0.2%487M+10.4%
Weighted-avg shares (diluted)496M-0.2%497M+1.0%492M+0.8%488M+0.2%487M+10.4%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
3.46B+7.6%3.21B-5.6%3.41B+3.9%3.28B+0.2%3.27B-4.2%
Cash & equivalents545M+16.5%468M+33.0%352M+2.0%345M-45.9%638M+28.9%
Accounts receivable873M+8.4%805M-4.4%842M+5.6%797M-4.3%833M-4.5%
Inventory1.74B+10.4%1.57B-9.3%1.74B+12.8%1.54B+12.2%1.37B-13.1%
Prepaid expenses236M-17.8%287M-7.4%310M-21.3%394M+66.2%237M-7.4%
13.4B+5.9%12.6B-12.2%14.4B-7.3%15.5B-6.0%16.5B-6.9%
Property, plant & equipment1.41B+41.9%993M-3.2%1.03B+2.7%999M-5.3%1.05B-19.8%
Operating lease right-of-use116M-4.9%122M-12.9%140M-0.7%141M-12.4%161M-13.9%
Goodwill4.78B+8.3%4.41B-13.3%5.09B-15.0%5.99B-2.9%6.17B-0.9%
Intangible assets3.41B-7.4%3.68B-18.1%4.49B-7.2%4.84B-13.3%5.59B-12.5%
Other non-current assets304M-2.3%311M-8.8%341M-9.8%378M-3.1%390M+12.1%
1.60B+21.4%1.31B+6.0%1.24B-27.1%1.70B+3.3%1.65B-20.7%
Accounts payable368M+24.3%296M+9.6%270M-30.8%390M-6.3%416M-17.0%
Deferred revenue416M+25.3%332M-9.5%367M+13.3%324M+1.6%319M+8.1%
Short-term & current debt74.0M+68.2%44.0M+15.8%38.0M-90.2%388M+32.0%294M-47.0%
Current lease liability38.0M+22.6%31.0M-3.1%32.0M+3.2%31.0M-8.8%34.0M-8.1%
Other current liabilities739M+58.6%466M+13.9%409M-9.9%454M+4.8%433M-25.6%
Finance lease liability (current)16.0M0.00———
6.81B+4.5%6.52B-19.9%8.14B-0.8%8.20B-8.6%8.97B-2.7%
Long-term debt3.76B-12.0%4.28B-25.4%5.74B+5.3%5.45B-9.6%6.03B+8.1%
Non-current lease liability86.0M-6.5%92.0M-16.4%110M-0.9%111M-12.6%127M-15.9%
Operating lease liability (total)124M+0.8%123M-13.4%142M+0.0%142M-11.8%161M-14.5%
Finance lease liability (total)255M0.00———
Finance lease liability239M0.00———
Deferred tax liabilities382M-14.9%449M-20.8%567M-14.4%662M-13.5%765M-15.0%
Other non-current liabilities585M+93.7%302M-26.5%411M+79.5%229M-12.6%262M-18.6%
6.55B+7.4%6.10B-2.0%6.22B-14.6%7.29B-2.9%7.51B-11.2%
Preferred stock0.000.00—0.000.00
Common stock0.000.000.000.000.00
Additional paid-in capital8.87B+0.6%8.82B+0.5%8.78B+0.4%8.74B+0.5%8.70B+0.5%
Retained earnings-2.18B-11.9%-1.95B+14.8%-2.29B-116.5%-1.06B-8.0%-979M-105.2%
Accumulated other comprehensive income-141M+81.7%-771M-189.8%-266M+32.1%-392M-87.6%-209M-169.0%
Total liabilities & equity13.4B+5.9%12.6B-12.2%14.4B-7.3%15.5B-6.0%16.5B-6.9%
Common shares issued497M+0.5%494M+0.3%493M+3.9%474M+0.2%473M+0.3%
Common shares outstanding497M+0.5%494M+0.3%493M+3.9%474M+0.2%473M+0.3%
Shares outstanding (cover)497M+0.5%495M+0.3%493M+0.3%492M+3.9%473M+0.2%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
560M+3.5%541M+99.6%271M-40.0%452M-6.4%483M+1278.0%
Depreciation & amortization680M+2.7%662M-4.6%694M+1.8%682M-4.7%716M+38.5%
Intangible amortization543M+3.0%527M-3.8%548M+3.8%528M-5.0%556M+54.4%
Share-based compensation68.0M+23.6%55.0M+19.6%46.0M-22.0%59.0M-10.6%66.0M+40.4%
Deferred income taxes-134M-19.6%-112M-40.0%-80.0M-40.4%-57.0M+61.5%-148M-29.8%
Change in inventory57.0M+229.5%-44.0M-127.5%160M-40.5%269M+1027.6%-29.0M-130.5%
Other operating activities-6.00M-300.0%3.00M-72.7%11.0M0.00-100.0%11.0M-35.3%
-279M-124.1%1.16B+785.2%-169M+5.6%-179M+66.2%-530M+88.9%
Capital expenditure276M+87.8%147M+5.0%140M-18.1%171M+7.5%159M+17.8%
Free cash flow284M-27.9%394M+200.8%131M-53.4%281M-13.3%324M+284.1%
Acquisitions0.00-100.0%41.0M+115.8%19.0M0.00-100.0%342M-93.2%
Proceeds from sale of PP&E———0.00-100.0%17.0M-76.4%
Other investing activities12.0M-14.3%14.0M+40.0%10.0M+25.0%8.00M+188.9%-9.00M+65.4%
-275M+81.6%-1.49B-1697.6%-83.0M+84.9%-549M-361.4%210M-95.8%
Long-term debt issued2.11B+501.7%350M0.00-100.0%425M-15.0%500M-89.6%
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.00-100.0%425M-15.0%500M-59.0%
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Other financing activities-2.00M+88.2%-17.0M-183.3%-6.00M+81.3%-32.0M-3.2%-31.0M-93.8%
FX effect on cash71.0M+178.0%-91.0M-658.3%-12.0M+29.4%-17.0M+45.2%-31.0M-214.8%
Net change in cash77.0M-33.6%116M+1557.1%7.00M+102.4%-293M-322.0%132M-18.0%
Interest paid206M-30.4%296M-21.9%379M+42.5%266M+20.4%221M+68.7%
Income taxes paid225M+60.7%140M+47.4%95.0M+2.2%93.0M-38.4%151M+55.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap11.3B+87.8%5.99B-18.4%7.34B+26.7%5.79B-56.8%13.4B-7.3%
P/E
—17.7×———
P/S2.4×+76.8%1.3×-19.7%1.7×+31.7%1.3×-54.7%2.8×-36.3%
P/B1.7×+74.9%1.0×-17.9%1.2×+38.7%0.9×-51.7%1.8×+4.5%
P/FCF39.6×+160.6%15.2×—11.8×-71.6%41.4×
Earnings yield
—5.6%———
FCF yield2.5%-61.6%6.6%—8.5%+251.9%2.4%
Source filing10-K10-K10-K10-K10-K

About this data

Source: ELAN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ELAN filings on SEC EDGAR → Not investment advice.